Using Artificial Intelligence to Phenotype Generalized Pustular Psoriasis (GPP)

March 9, 2026

Emerging applications of artificial intelligence are reshaping how rare inflammatory skin diseases are identified and characterized. Hear from Marta Jane Van Beek, MD, MPH, FAAD and Charles Dunn, MD as they discuss how large-scale clinical data can help refine phenotyping and improve care for patients with generalized pustular psoriasis.

Summary

Availability:

On-Demand

Expires on Mar 09, 2029

Credit Offered:

0.5 CME Credit

Recommended

Pediatric M&M in Dermatology

March 16, 2026

Examining unexpected outcomes can offer valuable insight into the pediatric dermatology practice. Join Nicole Noelani Harter, MD, FAAD and Vineet Mishra, MD, FAAD as they discuss how collaborative case review can inform decision-making and patient safety.

0.5 CME

Focus on Onychoscopy

March 2, 2026

Advances in dermoscopy are changing how nail disorders are approached in clinical practice. Listen as Matilde Iorizzo, PhD, MD, IFAAD and Flavia Fedeles, MD, FAAD explore how onychoscopy can enhance diagnostic accuracy and support earlier, more targeted management of nail disease.

0.5 CME

Atopic Dermatitis in Pediatric Patients

February 23, 2026

Advances in systemic therapy are changing how pediatric atopic dermatitis is understood and treated. Listen as Amy S. Paller, MD, FAAD and Emily Newsom, MD, FAAD explore how emerging treatments may influence disease course, comorbidities, and quality of life for children and their families.

0.5 CME

Evidence-Based Management of Melanocytic Neoplasms

March 23, 2026

Changing perspectives on melanocytic neoplasms are prompting reassessment of current long-standing practices. Listen as Jason Bok Lee, MD, FAAD and Hillary Johnson-Jahangir, MD, PhD, FAAD explore how risk stratification and emerging data can help refine management of pigmented lesions.

0.5 CME

Hidradenitis Suppurativa

March 30, 2026

A growing range of therapeutic options is influencing care for patients with hidradenitis suppurativa. Listen as Jennifer Hsiao, MD, FAAD and Jacquelyn Dosal, MD, FAAD examine how individualized, multimodal approaches can support more effective disease control.

0.5 CME

August JAAD: Rapid Clinical Response to Nemolizumab in Dermatologic Diseases Associated with Pruritus and Burning: A Multicenter Case Series

February 16, 2026

Refractory pruritus and burning symptoms can persist despite extensive evaluation and multiple therapies. In this episode, Jenny Eileen Murase, MD, FAAD and Elisa Gallo, MD, FAAD discuss how careful diagnostic workup and targeted treatment may offer rapid symptom relief while preserving clinical vigilance.

0.5 CME

Markers of Risk Not Pre-Melanomas: Case-Based Management of Dysplastic Nevi

February 9, 2026

Dysplastic nevi often generate uncertainty about melanoma risk and the need for re-excision. Listen as Suephy C. Chen, MD, FAAD and Lilia Correa-Selm, MD, FAAD reflect on how evidence-based classification and patient-centered follow-up can inform practical, risk-aware decision-making.

0.5 CME

Getting a Leg Up is Never Easy: Discover Novel Ways to Approach Reconstruction of the Leg, Ankle, and Foot

April 6, 2026

Reconstruction of the lower extremity presents unique surgical challenges, particularly when addressing defects of the leg, ankle, and foot. Join Daniel Brian Eisen, MD, FAAD and Charles Dunn, MD as they discuss how evolving reconstructive approaches can improve outcomes in these complex anatomical sites.

0.5 CME

Staging, Work-Up, and Management of High Risk Cutaneous Squamous Cell Carcinoma

February 2, 2026

High-risk cutaneous squamous cell carcinoma challenges clinicians to distinguish common disease from lesions with potentially serious outcomes. Join Kathryn Shahwan, MD, FAAD and M. Laurin Council, MD, FAAD as they discuss how thoughtful staging, risk stratification, and multidisciplinary care can guide management and long-term surveillance.

0.5 CME

What To Do When Patch Testing is Negative

January 12, 2026

A negative patch test can be an unexpected turning point in evaluating chronic dermatitis. Listen as Amber R. Atwater, MD, FAAD and Mona Sadeghpour, MD, FAAD reflect on how clinical intuition and patient dialogue can inform the next phase of assessment.

0.5 CME